Scientists, Publishers, Societies--and Turf

Graphic: Cathleen Heard This week, as the United Nations convenes its Millennium Summit in New York, delegates will consider how to help developing countries obtain better access to medical information on the Internet. The discussion is prompted by Secretary General Kofi Annan, who in his April Millennium Report proposed a Health InterNetwork and a volunteer U.N. Information Technology Service. The first proposal would establish thousands of online sites in hospitals and clinics to provide acce

Written byDave Amber
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Graphic: Cathleen Heard

This week, as the United Nations convenes its Millennium Summit in New York, delegates will consider how to help developing countries obtain better access to medical information on the Internet. The discussion is prompted by Secretary General Kofi Annan, who in his April Millennium Report proposed a Health InterNetwork and a volunteer U.N. Information Technology Service. The first proposal would establish thousands of online sites in hospitals and clinics to provide access to up-to-date medical information, and the second would train groups in how to exploit the Internet and information technology.

Recognizing the power of the Web for accessing medical and scientific information, these proposals intend to reach out to the disenfranchised. But developing countries are not the only disenfranchised who stand to benefit from Internet access to medical and scientific research. In the United States and Europe, outside of top-tier research institutions, some institutions cannot afford ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies